trial · primary record
gemcitabine, toripalimab, and lenvatinib capsules
Advanced Biliary Tract Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 39 |
| Primary completion | 2028-12-31 |
| Primary endpoint | ORR by RECIST v1.1 |
| Registry ID | NCT07897565 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:53.815Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07897565
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.